Search

Search Constraints

You searched for: Author/Creator Galindez, Eva

Search Results

1. 263 Time of response to immunosuppressive therapy for lupus nephritis patients. (April 2019)

2. 84 Comparative study in SLE patients with and without renal involvement by label free proteomic analysis of urine. (April 2019)

3. AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS. (June 2019)

4. AB0717 RELIABILITY OF SACROILIAC JOINT RADIOGRAPHS IN THE EARLY SPONDYLOARTHRITIS ESPERANZA COHORT. (June 2019)

5. AB0762 TREATMENT WITH TOFACITINIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTER STUDY OF CLINICAL PRACTICE. (June 2019)

6. FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS. (June 2019)

7. FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB. (June 2019)

8. No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort. Issue 2 (9th September 2020)

9. OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS. (June 2019)

10. P81 15 years experience in follow-up of pregnancy of autoimmune diseases in a multidisciplinary unit. (23rd March 2020)